NDAORALTABLETPriority Review
Approved
Oct 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 1w ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MAXZIDE is a fixed-dose combination oral tablet containing hydrochlorothiazide (a thiazide diuretic) and triamterene (a potassium-sparing diuretic) approved in 1984. It is indicated for hypertension management by combining two complementary diuretic mechanisms to reduce blood pressure while minimizing potassium depletion. The combination works synergistically: hydrochlorothiazide promotes sodium and water excretion while triamterene conserves potassium.
LOE Approaching
As LOE approaches, the brand team is likely contracting; career opportunities will focus on managed decline and generic transition support rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on MAXZIDE offers limited growth career opportunity given its LOE-approaching lifecycle and zero linked job openings. This role is best suited for professionals seeking stability in mature portfolio management, cost-containment strategies, or transition planning experience rather than high-visibility brand growth.
Brand ManagerField Sales Representative
Worked on MAXZIDE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.